Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
In Japan, two courses of CF therapy followed by surgery are accepted as a standard treatment for stage II/III oesophageal cancer according to the result of the JCOG9907 trial. However, some cases experience insufficient anti-tumour effects with CF therapy. We experienced a case with oesophageal cancer that underwent curative resection and DCF thera... Read More»
Kazuma Kobayashi, Shun Yamaguchi, Takuro Fujita, Takahiro Ikeda, Ayaka Ishii, Shunsuke Murakami, Kengo Kanetaka, Fumihiko Fujita, Kosho Yamanouchi, Naomi Hayashida, Chika Sakimura, Sayaka Kuba, Fusako Kawakami, Taiiichiro Kosaka, Amane Kitasato, Masaaki Hidaka, Akihiko Soyama, Shinichiro Oono, Yusuke Inoue, Shinichiro Kobayashi, Tamotsu Kuroki, Susumu Eguchi, Tomonori Tanaka and Naoe Kinoshita
Case Report: J Oncol Res Treat 2017. 2:1
Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article
Make the best use of Scientific Research and information from our 700 + peer reviewed, 黑料网 Journals